Trait Biosciences Reports Findings from Water-Soluble Cannabidiol (CBD) Formulation in Companion Animals
Trait Biosciences develops proprietary technologies that convert cannabinoids into water-soluble forms for improved performance and delivery.
Trait Biosciences' CBD82S™ water-soluble cannabidiol powder
14-day in-home evaluation observed owner-reported changes in mobility-related behaviors following topical CBD82S™ application
The 14-day assessment involved companion animals receiving daily topical application, dosed appropriately for their body weight. Owners reported changes in mobility-related behaviors over the evaluation period, including:
• Changes in ease of movement (walking, standing, jumping)
• Changes in activity levels and engagement
• Observable differences in comfort-related behavior and demeanor
Addressing Solubility and Formulation Constraints in Cannabinoid Development
Cannabidiol (CBD) has been studied for its potential roles in inflammation-related pathways and mobility-related outcomes in animal health. However, its broader utility in formulation development has been constrained by poor aqueous solubility, which can limit bioavailability, dosing consistency, and formulation flexibility.
Trait Biosciences has developed unique science-based solutions that convert hemp-derived cannabinoids into water-soluble forms using a number of technology processes, resulting in highly purified forms of CBD that address important limitations of conventional cannabinoids, including:
• Aqueous solubility
• Formulation stability and dosing consistency
• Compatibility with diverse delivery formats
By improving solubility at the molecular level, Trait ingredients expand formulation options for cannabinoid-infused products across animal health and other bioactive delivery applications.
CBD82S™ is Trait Biosciences’ lead water-soluble cannabidiol ingredient and the first of multiple cannabinoid molecules in development within its broader platform pipeline.
“Our focus is on applying biochemical and formulation science to address the fundamental solubility limitations of cannabinoids,” said Dr. Hanny Kanafani, President and COO of Trait Biosciences. “By enabling water-soluble forms, our technology is innovated to improve the functional benefits of CBD and performance characteristics such as consistency and absorption potential across delivery formats.”
About Trait Biosciences
Trait Biosciences is a biotechnology company focused on the development of proprietary technologies that convert cannabinoids into water-soluble forms to improve their formulation stability, solubility, and delivery characteristics. The company operates a B2B model, partnering with developers across animal health, nutraceutical, and bioactive formulation development applications to enable next-generation cannabinoid-based products.
For inquiries and collaboration opportunities, contact: info@traitbio.com
Thu Dang
Trait Biosciences
+1 626-200-5348
email us here
Visit us on social media:
LinkedIn
YouTube
Trait Biosciences' Water-Soluble CBD Technology Platform for Superior Bioavailability and Enhanced Efficacy
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
